News
CVS Health raised its full-year profit forecast on Thursday and said it plans to exit the market for Obamacare health ...
Prior to starting the trial, the participants also had moderate to high levels of scar tissue in the liver, known as stage 2 ...
4hon MSN
CVS Health said it will significantly expand access to the blockbuster weight loss drug Wegovy for patients covered by its ...
A large trial showed that the weight-loss drug could reduce liver inflammation and scarring caused by the common condition.
Novo Nordisk ( NVO 0.33%) stock jumped 3.1% at the open Thursday morning before drifting back. As of 10:54 a.m. ET, it was ...
Novo Nordisk saw a significant decline as it lost over 55% from its highs in June 2024. Check out the reasons for the decline ...
Novo Nordisk is collaborating with multiple telehealth organizations in an effort to increase patient access to authentic ...
The Danish drugmaker is expanding Wegovy access via telehealth providers like Hims and Ro. But the gap with Eli Lilly is only ...
Medical pioneers Hims & Hers Health (HIMS) and Novo Nordisk (NVO) are making headlines this week after announcing a partnership to expand obesity care in the telehealth space.
Doha: Ebn Sina Medical, a subsidiary of Aamal Company Q.P.S.C. and a leading supplier of pharmaceutical, and Novo Nordisk, ...
Hims & Hers launched a pharmacy-made weight-loss drug last year, taking advantage of an FDA rule allowing it to temporarily ...
A latest study has shown promising results in people suffering from metabolic dysfunction-associated steatohepatitis (MASH), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results